openPR Logo
Press release

Triple-Negative Breast Cancer Treatment Market size and Key Trends in terms of volume and value 2025

06-07-2018 01:41 PM CET | Health & Medicine

Press release from: Persistence Market Research

Triple-Negative Breast Cancer Treatment Market size and Key

Breast cancer is cancer that effects the breast tissue. Breast cancer is the most commonly diagnosed cancer among American women, besides skin cancer. Currently, to treat breast cancer various drugs like hormonal treatment, HER2 receptor-based drugs are available in the market. However, these drugs will not act against on triple-negative breast cancers this is mainly due to absence of receptors in triple-negative breast cancer conditions. Usually, in breast cancer cells they have receptors on their surface for HER2 protein, estrogen and progesterone hormones. If the breast cancer test shows positive for these receptors, it signifies breast cancer cells have receptors for estrogen, progesterone, and HER2 protein. These receptors are responsible for the growth of cancer.

However, these receptors are absent in triple-negative breast cancer conditions. Hence, triple breast cancer can't be treat with targeted therapies such as aromatase inhibitors and hormonal based therapies. Till date, there were no specific drugs in the market that can treat triple-negative breast cancer - leaving patients with fewer options by treating with surgery, radiotherapy and chemotherapy. In most of the cases, after performing surgery chemotherapy treatment is given - adjuvant chemotherapy. In some cases, chemotherapy is given before surgery - neoadjuvant chemotherapy. In this treatment procedure, it helps in reduction of tumor size of breast cancer. About 10-20% of breast cancers cases are triple-negative breast cancers.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/14305

Unmet need of triple-negative breast cancer is lack of proper interventions and treatment protocols. Few companies are trying to develop molecules that can treat triple-negative breast cancer conditions. For instance, Eribulin mesylate (Halaven®), developed by Eisai, completed clinical trials Phase 3 studies to treat triple-negative breast cancer conditions. In February 2016, Sacituzumab Govitecan (IMMU-132) got U.S. FDA breakthrough therapy designation for its treatment of triple-negative breast cancer conditions. IMMU-132 is an antibody-drug conjugate that acts by binding to protein Trop2 that overexpresses in triple breast cancer. Various other molecules are currently undergoing clinical trials to treat triple negative breast cancer.

According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. Triple-negative breast cancers are more aggressive and fewer survival rates when compared with breast cancer. Increase in incidence of breast cancers globally, and higher mortality rates related to breast cancers in developing countries are projected to driving the growth of this market during the forecast period. Lack of treatment regimens and proper drugs to treat this condition are hindering growth of this market.

Based on drug class, the global triple-negative breast cancer treatment market is divided into following

Alkylating agents
Platinum coordination complexes
Natural products
Plant Products
Taxanes
Microorganism Products
Anthracyclines
Antimetabolites
Microtubule stabilizing agents

Based on route of administration, the global triple-negative breast cancer treatment market is divided into following

Oral
Parenteral

Based on distribution channel, the global triple-negative breast cancer treatment market is divided into following

Hospital Pharmacies
Retail Pharmacies

Therapeutic area of triple-negative breast cancer treatment market was segmented into alkylating agents, natural products, antimetabolites and microtubule stabilizing agents. Alkylating agents is further segmented into Platinum coordination complexes. Natural products category is segmented into Plant products and Microorganism products.

Based on the route of administration, the triple-negative breast cancer treatment market was segmented into oral and parenteral. Parenteral route occupies the major market share followed by the oral route.

On the basis of the distribution channel, triple-negative breast cancer treatment market is segmented into hospital and retail pharmacies Hospital pharmacies accounts largest market share due to availability of these drugs in hospitals to treat breast cancer

Based on the geographic region, triple-negative breast cancer treatment market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America occupies the major market share due to high research activities on triple-negative breast cancer, buying power of patients are the major factors boosting the growth of this market during the forecast period. Asia Pacific region is expected to grow with highest CAGR over the forecast period due to high incidence and mortality rates of breast cancer condition in this region.

Request to View TOC @ https://www.persistencemarketresearch.com/toc/14305

Some of the players in triple-negative breast cancer treatment market include Celgene, Roche, Immunomedics GmbH, Merck & Co., Inc., F. Hoffmann-La Roche Ltd and Eisai Co., Ltd.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Triple-Negative Breast Cancer Treatment Market size and Key Trends in terms of volume and value 2025 here

News-ID: 1074272 • Views: 199

More Releases from Persistence Market Research

Membrane Technology Market Key Players, Trends, Share, Size, Growth, Opportunity …
Membrane Technology Market 2022 The global Membrane Technology Market is stipulated to witness a CAGR of 9.1% and reach USD 7,029.9 million by the year 2022. Digital innovation is the buzzword. As such, digital health unicorns are coming up. Digital upswinging is thus expected to take the entire healthcare vertical by storm in the next 10 years. This would be the state of the healthcare vertical in the near future. Get Free
Semiconductor Assembly Test Services Market Sales to Top US$ 58 Bn by 2031
Semiconductor Assembly Test Services Market 2022 Semiconductor Assembly Test Services Market is projected to expand steadily at a CAGR of close to 6% to reach US$ 58 Bn in the next 10 years In a new Persistence Market Research report, the semiconductor assembly and testing services (SATS) market is projected to expand at a healthy CAGR of close to 6% during the forecast period of 2022 to 2031,with the market valued at
Automated Cell Counters Market To Witness A Customized Procurement Strategy At A …
The global Automated Cell Counters Market is expected to witness a CAGR of 5.8% by the year 2029. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's situation in the upcoming period. According
Photodynamic Therapy Market to flourish based on virtual, personalized care
The healthcare vertical is seeing an influx of self-moving smart devices, which ought to extend support to the medical staff by curtailing their supply management or sanitation-related chores. Smart helpers could be used for remote monitoring of oxygen saturation and blood pressure levels for the patients, as they are of utmost importance regarding their health condition. This would be the scenario with Photodynamic Therapy Market in the subsequent decade. Actinic keratosis,

All 5 Releases


More Releases for Breast

Breast Reduction Bangalore
The Pros and Cons of a Breast Reduction: All of these symptoms can be a telltale sign your breasts are too heavy for your frame: Pressure on the shoulders caused by bra straps supporting too much weight. Severe back and neck pain. Numbness in your hands and fingers. Headaches. Shortness of breath. Breast reduction is a surgical procedure that reduces the size and weight of the breasts. It has proven to be a popular solution to alleviate
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” the
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can
Global Breast Pumps Market
The Global Breast Pumps Market was valued at US$ 606.6 million in 2015 and is projected to expand at a CAGR of 4.8% during 2016–2024,according to a new report published by Coherent Market Insights. Rapidly growing population and improving insurance scenario is propelling demand for breast pumps worldwide. Demand for electronic breast pumps is gaining high traction in terms mainly due to adjustable suction level aiding ease of use. A more
Liposuction Breast Reduction
Portsmouth, NH - Liposuction Breast Reduction, also known as Scarless Breast Reduction continues to gain in popularity over the traditional method of breast reduction for the relief of back, neck and shoulder pain. More and more patients are dissatisfied with the older method and are requesting the less invasive method over the twelve inches of scarring per breast. Plastic Surgeons are responding to their patients and are performing more and
Breast Cancer-Breast Conservation Is A Possibility
New Delhi - April 27, 2011: The incidence of breast cancer is rapidly increasing in India and has overtaken cancer of cervix in Indian women in metropolitan cities. One in 22 Indian women are likely to develop breast cancer during their lifetime. Breast cancer is a disease of old age with the peak incidence in the fifth and sixth decades - but in India the disease is seen a decade